Clinicopathological significance of GADD45 gene alterations in human familial breast carcinoma

Breast Cancer Research and Treatment

Volumn 87, Issue 2, 2004, Pages 197-201

  Sensi, Elisa ^a   Tancredi, Mariella ^a   Aretini, Paolo ^a   Cipollini, Giovanna ^a   Collecchi, Paola ^a   Naccarato, A Giuseppe ^a   Viacava, Paolo ^a   Bevilacqua, Generoso ^a   Caligo, Maria A ^a  

^a Division of Surgical   (Italy)

Author keywords

GADD45 gene; hereditary breast cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN P53;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CARCINOMA; CANCER SCREENING; COMPARATIVE STUDY; CONTROLLED STUDY; DNA DAMAGE; FAMILIAL CANCER; GENE LOCUS; GENETIC ANALYSIS; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPONTANEOUS MUTATION; WILD TYPE;

BREAST NEOPLASMS; CARCINOMA; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LOSS OF HETEROZYGOSITY; PEDIGREE; PROTEINS;

EID: 4544320756     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000041625.60280.4a     Document Type: Article

References (21)

1. Carrier F, Smith ML, Bae I, Kilpatrick KE, Lansing TJ, Chen CY, Engelstein M, Friend SH, Henner WD, Gilmer TM: Characterization of human Gadd45, a p53-regulated protein. J Biol Chem 269: 32672-32677, 1994
2. Kearsey JM, Coates PJ, Prescott AR, Warbrick E, Hall PA: Links Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene 11: 1675-1683, 1995
3. Fornace AJ Jr, Jackman J, Hollander MC, Hoffman-Liebermann B, Liebermann DA: Genotoxic-stress-response genes and growth-arrest genes, gadd, MyD, and other genes induced by treatments eliciting growth arrest. Ann N Y Acad Sci 21: 663: 139-153, 1992
4. Papathanasiou MA, Kerr NC, Robbins JH, McBride OW, Alamo I Jr, Barrett SF, Hickson ID, Fornace AJ Jr: Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. Mol Cell Biol 11: 1009-1016, 1991
5. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597, 1992
6. Zhan Q, Bae I, Kastan MB, Fornace AJ Jr: The p53-dependent gamma-ray response of GADD45. Cancer Res 54: 2755-2760, 1994
7. Fornace AJ Jr, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ: Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 10: 4196-4203, 1989
8. Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW, Fornace AJ Jr: Analysis of the mammalian gadd45 gene and its response to DNA damage. J Biol Chem 268: 24385-24393, 1993
9. Rodriguez E, Sreekantaiah C, Chaganti RS: Genetic changes in epithelial solid neoplasia. Cancer Res 54: 3398-3406, 1994
10. Hoggard N, Hey Y, Brintnell B, James L, Jones D, Mitchell E, Weissenbach J, Varley JM: Identification and cloning in yeast artificial chromosomes of a region of elevated loss of heterozygosity on chromosome 1p31.1 in human breast cancer. Genomics 30: 233-243, 1995
11. Campomenosi P, Hall PA: Gadd45 mutations are uncommon in human tumour cell lines. Cell Prolif 33: 301-306, 2000
12. Yamasawa K, Nio Y, Dong M, Yamaguchi K, Itakura M: Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer. Clin Cancer Res 8: 2563-2569, 2002
13. Blaszyk H, Hartmann A, Sommer SS, Kovach JS: A polymorphism but no mutations in the GADD45 gene in breast cancers. Hum Genet 97: 543-547, 1996
14. Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA: Induction of GADD45 and JNK/ SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97: 575-586, 1999
15. Hartman AR, Ford JM: BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat Genet 32: 180-184, 2002
16. Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins A-M, Dite GS, McCredie MRE, Giles GG, Hopper JL, Venter DJ: Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res 59: 2011-2017, 1999
17. Crook T, Brooks LA, Crassland S, Osin P, Barker KT, Waller J, Philp E, Smith PD, Yuluk I, Peto J, Parker G, Allday MJ, Crompton MR, Gusterson BA: p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumors. Oncogene 17: 1681-1689, 1998
18. Ramus SJ, Bobrow LG, Pharoah PDP, Finnigan DS, Fishman A, Altaras M, Harrington PA, Gayther SA, Ponder BAJ, Friedman LS: Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours. Genes Chromosomes Cancer 25: 91-96, 1999
19. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace AJ Jr: Genomic instability in Gadd45a-deficient mice. Nat Genet 23: 176-184, 1999
20. Sensi E, Tancredi M, Aretini P, Cipollini G, Naccarato AG, Viacava P, Bevilacqua G, Caligo MA: p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations. Breast Cancer Res Treat 82: 1-9, 2003
21. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, New York, 1989